Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease-Reference-Cited by-同舟云学术

Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease

Published:2018-01-03 Issue:1 Volume:8 Page:3
ISSN:2075-4426
Container-title:Journal of Personalized Medicine
language:en
Short-container-title:JPM

Author:

Cacabelos Ramón,Meyyazhagan Arun,Carril Juan,Cacabelos Pablo,Teijido Óscar

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Link

http://www.mdpi.com/2075-4426/8/1/3/pdf

Reference76 articles.

1. The application of functional genomics to Alzheimer’s disease

2. Molecular pathology and pharmacogenomics in Alzheimer’s disease: Polygenic-related effects of multifactorial treatments on cognition, anxiety, and depression;Cacabelos;Methods Find. Exp. Clin. Pharmacol.,2007

3. Pharmacogenomics and therapeutic strategies for dementia

4. Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular component

5. Cerebral Perfusion Enhancing Interventions: A New Strategy for the Prevention of Alzheimer Dementia

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy;Pharmacological Research;2024-07

2. Symptoms and conventional treatments of Alzheimer's disease;Alzheimer's Disease and Advanced Drug Delivery Strategies;2024

3. Pharmacogenetics of anxiety and depression in Alzheimer's disease;Pharmacogenomics;2023-01

4. A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics;Diagnostics;2022-11-28

5. Communicating and Using Dementia Risk Evidence;Journal of Alzheimer's Disease;2022-11-22